Cathinone-related mortality: khat, mephedrone and related novel psychoactive substances and their role in deaths – the UK experience

Research output: Contribution to journalMeeting abstractpeer-review

Abstract

This paper will present an overview of the work undertaken in the UK to
establish a solid evidence base on the relationships between khat, mephedrone,
and related novel psychoactive substances to mortality. The processes of case
criteria and classifi cation, case identifi cation and verifi cation, data sources and
collection activities will be explained, emphasising the ethical and practical
considerations that have to be met. Up to date information from the National
Programme on Substance Abuse Deaths will be presented showing what is
currently known about these substances with regard to their associations
with fatalities, and the gaps in knowledge that remain. The implications
of the lack of information about these substances, especially in a period of
increasingly rapid changes in drug supply and consumption patterns, will be
outlined in respect of approaches to treatment, education, prevention, and
regulation.
Original languageEnglish
Pages (from-to)46-47
Number of pages2
JournalAddictologia Hungarica
VolumeSupplement
Issue number1
Publication statusPublished - 12 Mar 2012
EventFirst International Conference on Novel Psychoactive Substances (NPS) - HOTEL BENZCÚR, Budapest, Hungary
Duration: 12 Mar 201213 Mar 2012

Fingerprint

Dive into the research topics of 'Cathinone-related mortality: khat, mephedrone and related novel psychoactive substances and their role in deaths – the UK experience'. Together they form a unique fingerprint.

Cite this